Cargando…
Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer
BACKGROUND: Prognostication of Breast Cancer (BC) relies largely on traditional clinical factors and biomarkers such as hormone or growth factor receptors. Due to their suboptimal specificities, it is challenging to accurately identify the subset of patients who are likely to undergo recurrence and...
Autores principales: | Krishnan, Preethi, Ghosh, Sunita, Wang, Bo, Li, Dongping, Narasimhan, Ashok, Berendt, Richard, Graham, Kathryn, Mackey, John R., Kovalchuk, Olga, Damaraju, Sambasivarao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587870/ https://www.ncbi.nlm.nih.gov/pubmed/26416693 http://dx.doi.org/10.1186/s12864-015-1899-0 |
Ejemplares similares
-
The Regulatory Mechanism of miR-574-5p Expression in Cancer
por: Huang, Wei, et al.
Publicado: (2022) -
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment
por: Proestler, Eva, et al.
Publicado: (2023) -
Circulating miR-103a-3p and miR-660-5p are associated with bone parameters in patients with controlled acromegaly
por: Valassi, Elena, et al.
Publicado: (2018) -
MiR-574-5p: A Circulating Marker of Thoracic Aortic Aneurysm
por: Boileau, Adeline, et al.
Publicado: (2019) -
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells
por: Salati, Simona, et al.
Publicado: (2017)